Literature DB >> 6754744

Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells.

D D Wagner, J B Olmsted, V J Marder.   

Abstract

Immunofluorescence staining of cultured human umbilical vein endothelial cells has shown the presence of von Willebrand protein in the perinuclear region, in small rodlike structures through the cytoplasm, and on filaments of the extracellular matrix. Nonendothelial cells showed no staining with anti-von Willebrand protein antiserum. At the light microscope level, immunoperoxidase treatment of endothelial cells revealed the same pattern and antibody specificity as the fluorescence staining. Thin sections of the peroxidase-stained cells showed decorated filaments close to the substratum and also specific deposits in the endoplasmic reticulum and Weibel-Palade bodies. Control antisera against other selected proteins in endothelial cells failed to stain the Weibel-Palade bodies. These data suggest that the Weibel-Palade bodies of endothelial cells are storage and/or processing organelles for von Willebrand protein.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6754744      PMCID: PMC2112360          DOI: 10.1083/jcb.95.1.355

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  23 in total

1.  Cultured aortic endothelial cells from pigs with von Willebrand disease: in vitro model for studying the molecular defect(s) of the disease.

Authors:  F M Booyse; A J Quarfoot; S Bell; D N Fass; J C Lewis; K G Mann; E J Bowie
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

Review 2.  Biosynthesis of procollagen.

Authors:  J H Fessler; L I Fessler
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

3.  10 nm filaments in normal and transformed cells.

Authors:  R O Hynes; A T Destree
Journal:  Cell       Date:  1978-01       Impact factor: 41.582

4.  Absence of acid phosphatase activity in specific endothelial organelles.

Authors:  A Lemeunier; P H Burri; E R Weibel
Journal:  Histochemie       Date:  1969

5.  Surface distribution of LETS protein in relation to the cytoskeleton of normal and transformed cells.

Authors:  V Mautner; R O Hynes
Journal:  J Cell Biol       Date:  1977-12       Impact factor: 10.539

6.  Synthesis of antihemophilic factor antigen by cultured human endothelial cells.

Authors:  E A Jaffe; L W Hoyer; R L Nachman
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

7.  Clonal growth of bovine vascular endothelial cells: fibroblast growth factor as a survival agent.

Authors:  D Gospodarowicz; J Moran; D Braun; C Birdwell
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

8.  Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes.

Authors:  R Nachman; R Levine; E A Jaffe
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

9.  Golgi origin of tubular inclusions in endothelial cells.

Authors:  A Sengel; P Stoebner
Journal:  J Cell Biol       Date:  1970-01       Impact factor: 10.539

10.  Human vascular endothelial cells in culture. Growth and DNA synthesis.

Authors:  M A Gimbrone; R S Cotran; J Folkman
Journal:  J Cell Biol       Date:  1974-03       Impact factor: 10.539

View more
  185 in total

1.  The tetraspanin CD63/lamp3 cycles between endocytic and secretory compartments in human endothelial cells.

Authors:  T Kobayashi; U M Vischer; C Rosnoblet; C Lebrand; M Lindsay; R G Parton; E K Kruithof; J Gruenberg
Journal:  Mol Biol Cell       Date:  2000-05       Impact factor: 4.138

Review 2.  Secretory pathways in endothelin synthesis.

Authors:  F D Russell; A P Davenport
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

3.  Localization of alpha 1,3-fucosyltransferase VI in Weibel-Palade bodies of human endothelial cells.

Authors:  S Schnyder-Candrian; L Borsig; R Moser; E G Berger
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

4.  Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen.

Authors:  H Ni; C V Denis; S Subbarao; J L Degen; T N Sato; R O Hynes; D D Wagner
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

5.  Correction of a murine model of von Willebrand disease by gene transfer.

Authors:  Robert G Pergolizzi; Guangchun Jin; Diane Chan; Lorraine Pierre; James Bussel; Barbara Ferris; Philip L Leopold; Ronald G Crystal
Journal:  Blood       Date:  2006-04-25       Impact factor: 22.113

6.  Rickettsia rickettsii infection of cultured human endothelial cells induces heme oxygenase 1 expression.

Authors:  Elena Rydkina; Abha Sahni; David J Silverman; Sanjeev K Sahni
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

7.  Nuclear factor kappa B protects against host cell apoptosis during Rickettsia rickettsii infection by inhibiting activation of apical and effector caspases and maintaining mitochondrial integrity.

Authors:  Suresh G Joshi; Charles W Francis; David J Silverman; Sanjeev K Sahni
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

8.  Protein kinase C-delta and phosphatidylinositol 3-kinase/Akt activate mammalian target of rapamycin to modulate NF-kappaB activation and intercellular adhesion molecule-1 (ICAM-1) expression in endothelial cells.

Authors:  Mohd Minhajuddin; Kaiser M Bijli; Fabeha Fazal; Antonella Sassano; Keiichi I Nakayama; Nissim Hay; Leonidas C Platanias; Arshad Rahman
Journal:  J Biol Chem       Date:  2008-12-13       Impact factor: 5.157

9.  Immunohistochemical localization of vascular endothelial cell factor VIII/von Willebrand factor antigen in human normal and disordered gastric tissues.

Authors:  S L Shen; Y H Xu; Z B Wu
Journal:  J Tongji Med Univ       Date:  1989

10.  Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart.

Authors:  H Urata; K D Boehm; A Philip; A Kinoshita; J Gabrovsek; F M Bumpus; A Husain
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.